Company Filing History:
1 out of 21 
1 out of 1,744 
1 out of 870 
Years Active: 2021-2024
Title: Innovations by Noémie Caillot in Immunotherapy
Introduction
Noémie Caillot, an accomplished inventor based in Paris, France, has made significant strides in the field of immunotherapy. With a total of two patents to his name, he is recognized for his groundbreaking work in developing novel immunogenic products and markers used in evaluating immunotherapy efficacy.
Latest Patents
One of Caillot's latest patents is titled "Immunogenic product comprising IL-4 and/or IL-13 for treating disorders associated with aberrant IL-4 and/or IL-13 expression or activity." This patent focuses on an immunogenic product that includes a cytokine conjugated with a carrier protein, specifically CRM, targeting the cytokines IL-4 and IL-13. The invention also encompasses a method of manufacturing this immunogenic product and outlines its therapeutic use in treating inflammatory disorders linked to aberrant expression or activity of IL-4 and IL-13.
Another significant patent attributed to Caillot is "Sialylated fetuin-A as a marker of immunotherapy efficacy." This invention emphasizes the identification of specific polypeptides and their variants that can serve as effective markers to gauge the efficiency of immunotherapy. This work is particularly valuable in predicting how responsive a patient may be to immunotherapy treatments.
Career Highlights
Throughout his career, Noémie Caillot has worked with notable institutions such as Neovacs and the Institut National de la Santé et de la Recherche Médicale (INSERM). His contributions to the field have established him as a prominent figure in the research of immunotherapeutic applications.
Collaborations
Caillot has collaborated with talented professionals like Géraldine Grouard-Vogel and Eva Conde García, contributing to the advancement of innovative solutions in the medical field. These partnerships highlight his ability to work within teams to foster breakthroughs in immunotherapy efficacy.
Conclusion
Noémie Caillot's contributions to the fields of immunotherapy and patentable innovations reflect a dedicated pursuit of scientific progress. His inventions not only demonstrate the potential for therapeutic advancements but also underline the importance of collaboration in achieving medical breakthroughs. Through his work, he continues to influence the landscape of immunotherapy and patient care.